This is the authors' abstract. We don't add key points for this paper.
Structured Abstract: Objective Thoracic duct embolization (TDE) has been used for refractory chylothorax in patients unfit for surgical thoracic duct ligation (SDL). We hypothesized that TDE can be employed more broadly. Methods Retrospective review of postoperative chylothorax from 2018-2024. Data included, risk factors, chest tube outputs, and management. Descriptive, and univariate analyses were used to develop an algorithmic approach to chylothorax management. Results 73 patients developed postoperative chylothorax. The most common operations were pulmonary resection (n=27, 37%), and esophagectomy (n=24, 33%). 66 patients were treated with dietary modification (63 NPO, 3 low-fat) and 25/66 (38%) chyle leaks resolved. 40 patients had persistent chyle leak and underwent a procedure (35 TDE, 4 SDL, 1 sclerotherapy). Chest tube volume >=1130 mL before dietary modification (PPV 91%) and >=375 mL 48 hours after dietary change (PPV 97%) were predictive of failed conservative treatment. TDE was successful in 83% of cases (n=29/35) following failed dietary modification. Success of TDE did not vary by initial operation (p=0.69). There were 2 (2/40, 5%) major complications after TDE. Cisterna chyli cannulation (52% vs 83%, p=0.05), and successful intervention at lymphangiogram (65% vs 94%, p=0.05) improved over time (2018-2021 vs. 2022-2024). Conclusions Chest tube volume predicts failure and identifies patients who would benefit from early intervention. Within the context of our institutional capabilities, TDE is a safe and effective second line therapy regardless of the index operation. Technical success rates of TDE can improve over time with increased experience.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Aizpuru et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: